At a glance
- Originator Pfizer
- Class Antifungals
- Mechanism of Action Myristoyl transferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Aspergillosis; Candidiasis
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Aspergillosis in United Kingdom (unspecified route)
- 15 Dec 2003 No development reported - Preclinical for Candidiasis in United Kingdom (unspecified route)
- 27 Apr 2001 New profile